Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide weight loss therapy typically begins at low doses and increases over 16-20 weeks, with most patients reaching meaningful results between 1.0 and 2.4 mg weekly. PlexusDx compounded semaglutide injections start at $149/month regardless of your current dose level, ensuring your medication stays affordable as your treatment advances.
How Semaglutide Dosing Works for Weight Management
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves blood sugar control. The medication works most effectively when doses are titrated—gradually increased—over several weeks. This gradual approach allows your body to adapt while minimizing nausea and other adjustment-period side effects that can occur with rapid dose escalation.
A typical semaglutide dosing schedule begins at 0.25 mg weekly and increases by 0.25 mg every four weeks until reaching a therapeutic dose. Most individuals experience significant weight loss benefits between 1.0 and 2.4 mg weekly, though some may benefit from higher doses under medical supervision. Your PlexusDx clinician will monitor your progress, tolerance, and weight loss velocity to determine if dose continuation, maintenance, or adjustment is appropriate for your goals.
When to Consider Increasing Your Semaglutide Dose
Dose escalation typically occurs when weight loss plateaus after 4-6 weeks at a stable dose, or when your appetite suppression decreases over time. This phenomenon, called tachyphylaxis, is normal and does not indicate treatment failure—it simply means your body has adapted to the current dose level. Increasing to the next 0.25 mg increment usually restores appetite control and weight loss momentum.
Other indicators for dose adjustment include insufficient satiety during meals, return of food cravings, or slowed weight loss progression despite diet and exercise adherence. PlexusDx clinicians use real-time patient feedback and biometric data to recommend timing for dose increases. Important: dose increases are always clinician-directed and based on individual response, not predetermined schedules.
The Role of Genetic Testing in Optimizing Your Dose
PlexusDx Precision Peptide Genetic Test identifies variants in four key genes that influence GLP-1 pathway sensitivity: GLP1R rs6923761, GIPR rs1800437, MC4R rs17782313, and FTO rs9939609. These variants affect how your body responds to semaglutide and may predict whether you will achieve robust weight loss at standard doses or may benefit from earlier dose escalation. This $99 genetic test is available as an add-on after your first month of treatment and maps 14 distinct metabolic pathways.
Understanding your genetic profile allows PlexusDx clinicians to personalize your dosing strategy, anticipate your individual response pattern, and adjust expectations realistically. Patients with certain GLP1R variants may experience more pronounced appetite suppression at lower doses, while others with FTO variants may require higher doses to overcome genetic predisposition to weight gain. Genetic insights remove guesswork from dose optimization.
Pricing and Access: Your Dose Goes Up, Your Price Stays the Same
PlexusDx compounded semaglutide injections cost $149 per month across all dose levels, from 0.25 mg through 2.4 mg and beyond. This flat-rate pricing model means that as your clinician increases your dose to optimize weight loss, your monthly cost remains completely predictable—no hidden dose-ladder pricing, no surprise increases. PlexusDx serves all 50 states without insurance requirements, memberships, or enrollment fees.
Your treatment is HSA/FSA eligible, and compounded semaglutide is prepared at licensed 503A compounding pharmacies under strict quality standards. Monthly costs are transparent from day one, making it easy to budget for long-term weight management. Many patients find compounded semaglutide at $149/month more accessible than brand-name alternatives, especially over the 6-12 month treatment timeline typical for meaningful weight loss.
Managing Side Effects During Dose Escalation
Nausea, constipation, and appetite suppression are common during the first few weeks after each dose increase, typically resolving within 3-5 days as your body adjusts. Staying hydrated, eating smaller frequent meals, and consuming adequate fiber can significantly reduce gastrointestinal discomfort. Your PlexusDx clinician will provide specific dietary and hydration guidance tailored to your dose level.
If side effects persist beyond one week or are severe, inform your PlexusDx team immediately—dose increases may be slowed or temporarily paused. This is not failure; it reflects appropriate medical oversight. Most patients find that their tolerance improves with each successive dose increase, and final side effect burden is minimal by the time therapeutic dose is reached.
Expected Weight Loss Timeline with Progressive Semaglutide Dosing
Clinical trials show that semaglutide weight loss accelerates as doses increase over the first 16-20 weeks of therapy. At 0.5 mg weekly, average weight loss is 3-5% of body weight over 12 weeks. By 1.0 mg weekly, many patients achieve 8-10% weight loss, and at 2.4 mg weekly, average losses reach 15-20% of starting weight over 68 weeks of continuous treatment.
Individual results vary significantly based on genetics, baseline metabolic rate, diet quality, physical activity, sleep, and stress levels. PlexusDx genetic testing helps predict your likely response trajectory, so your clinician can set realistic timelines and recognize whether your weight loss pattern is on track or requires intervention. Consistency over the full 6-12 month treatment cycle produces the most meaningful, sustainable results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the maximum semaglutide dose for weight loss?
The standard therapeutic range for semaglutide weight loss is 1.0 to 2.4 mg injected weekly. Some patients may benefit from doses higher than 2.4 mg under close medical supervision, but this is determined individually by your PlexusDx clinician based on tolerance and response. Dose escalation is always gradual and monitored.
How often should my semaglutide dose be increased?
Standard dosing increases by 0.25 mg every four weeks until reaching an effective dose, usually 1.0-2.4 mg weekly. However, your PlexusDx clinician may adjust this timeline based on your weight loss progress, side effect tolerance, and individual goals. Some patients maintain doses longer if results are strong; others escalate faster if tolerated well.
Does PlexusDx charge more for higher semaglutide doses?
No. PlexusDx compounded semaglutide injections are $149 per month flat, regardless of whether you are at 0.25 mg or 2.4 mg weekly. Your dose may increase as treatment progresses, but your price remains the same—no hidden dose-ladder fees, no surprise charges.
Can I skip a dose increase if I am losing weight?
Yes. If you are achieving steady weight loss and tolerating your current dose well, your PlexusDx clinician may recommend maintaining that dose longer before escalating. Dose increases are never mandatory; they are suggested when weight loss slows, appetite returns, or your clinical response indicates readiness for advancement.
How does the Precision Peptide Genetic Test help with my semaglutide dose?
PlexusDx Precision Peptide Genetic Test analyzes four key genetic variants affecting GLP-1 receptor sensitivity and appetite control pathways. Results predict whether you will respond robustly at standard doses or may benefit from earlier escalation, allowing your clinician to personalize your dosing strategy for faster, more effective results. The test costs $99 and is available after your first month of treatment.
What happens if I experience bad nausea when my dose increases?
Contact your PlexusDx clinician immediately. Side effects like nausea typically resolve within 3-5 days, but if severe, your dose increase may be slowed or temporarily paused. Staying hydrated and eating smaller meals helps; your clinician will provide specific guidance. Managing side effects properly is essential to completing your treatment successfully.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Ozempic Journey: Should You Eat Before Your Shot?
Do You Lose Weight on Wegovy? Exploring the Science and Success Stories